Feasibility and outcome of concurrent chemoradiotherapy for recurrent cervical carcinoma after initial surgery

Tumori

Volumn 96, Issue 4, 2010, Pages 553-559

  Lee, Yu Sun ^a   Kim, Young Seok ^a   Kim, Jong Hoon ^a   Ahn, Seung Do ^a   Lee, Sang Wook ^a   Shin, Seong Soo ^a   Nam, Joo Hyun ^b   Kim, Young Tak ^b   Kim, Yong Man ^b   Kim, Jong Hyeok ^b   Choi, Eun Kyung ^a  

^a University of Ulsan   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Chemoradiotherapy; Recurrence; Uterine cervical cancer

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CISPLATIN; COLONY STIMULATING FACTOR; FLUOROURACIL; IFOSFAMIDE; IRIDIUM 192; MIROSELECTRON; PACLITAXEL; UNCLASSIFIED DRUG; VINBLASTINE; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CYSTOVAGINAL FISTULA; DISEASE FREE SURVIVAL; DRUG EFFICACY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; HYSTERECTOMY; ILEUS; IRRADIATION; KIDNEY DYSFUNCTION; MEDICAL RECORD REVIEW; NAUSEA AND VOMITING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PELVIS; RADIATION DOSE; RECTOVAGINAL FISTULA; RECTUM HEMORRHAGE; RECURRENT CANCER; RETROSPECTIVE STUDY; SALVAGE THERAPY; SURVIVAL RATE; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR VOLUME; UROGENITAL TRACT DISEASE; UTERINE CERVIX CARCINOMA; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; EPIDEMIOLOGY; KAPLAN MEIER METHOD; KOREA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MEDICAL RECORD; MIDDLE AGED; MORTALITY; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PROCEDURES; UTERINE CERVICAL NEOPLASMS;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; CHEMOTHERAPY, ADJUVANT; FEASIBILITY STUDIES; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; KOREA; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MEDICAL RECORDS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 77957203716     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089161009600407     Document Type: Article

References (37)

1. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin, 55: 74-108, 2005.
2. Kim YT: Current status of cervical cancer and HPV infection in Korea. J Gynecol Oncol, 20: 1-7, 2009.
3. Burghardt E, Baltzer J, Tulusan AH, Haas J: Results of surgical treatment of 1028 cervical cancers studied with volumetry. Cancer, 70: 648-655, 1992.
4. Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, Major F: Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol, 38: 352-357, 1990. (Pubitemid 20362555)
5. Fiorica J, Holloway R, Ndubisi B, Orr J, Grendys E, Boothby R, DeCesare S, LaPolla J, Hoffman M, Patel J: Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervix. Gynecol Oncol, 85: 89-94, 2002. (Pubitemid 34304015)
6. Long HJ, 3rd, Bundy BN, Grendys EC, Jr., Benda JA, McMeekin DS, Sorosky J, Miller DS, Eaton LA, Fiorica JV: Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study. J Clin Oncol, 23: 4626-4633, 2005. (Pubitemid 46224065)
7. Moore DH, Blessing JA, McQuellon RP, Thaler HT, Cella D, Benda J, Miller DS, Olt G, King S, Boggess JF, Rocereto TF: Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol, 22: 3113-3119, 2004.
8. Nguyen HN, Nordqvist SR: Chemotherapy of advanced and recurrent cervical carcinoma. Semin Surg Oncol, 16: 247-250, 1999. (Pubitemid 29177586)
9. Waggoner SE: Cervical cancer. Lancet, 361: 2217-2225, 2003.
10. Haasbeek CJ, Uitterhoeve AL, van der Velden J, Gonzalez DG, Stalpers LJ: Long-term results of salvage radiotherapy for the treatment of recurrent cervical carcinoma after prior surgery. Radiother Oncol, 89: 197-204, 2008.
11. Ijaz T, Eifel PJ, Burke T, Oswald MJ: Radiation therapy of pelvic recurrence after radical hysterectomy for cervical carcinoma. Gynecol Oncol, 70: 241-246, 1998. (Pubitemid 28430937)
12. Ito H, Shigematsu N, Kawada T, Kubo A, Isobe K, Hara R, Yasuda S, Aruga T, Ogata H: Radiotherapy for centrally recurrent cervical cancer of the vaginal stump following hysterectomy. Gynecol Oncol, 67: 154-161, 1997. (Pubitemid 27500411)
13. Jobsen JJ, Leer JW, Cleton FJ, Hermans J: Treatment of locoregional recurrence of carcinoma of the cervix by radiotherapy after primary surgery. Gynecol Oncol, 33: 368-371, 1989. (Pubitemid 19148741)
14. Tan R, Chung CH, Liu MT, Lai YL, Chang KH: Radiotherapy for postoperative recurrent uterine cervical carcinoma. Acta Oncol, 30: 353-356, 1991.
15. Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL, 3rd., Walker JL, Gersell D: Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med, 340: 1154-1161, 1999.
16. Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, Rotman M, Gershenson DM, Mutch DG: Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med, 340: 1137-1143, 1999. (Pubitemid 29177872)
17. Peters WA, 3rd, Liu PY, Barrett RJ, 2nd, Stock RJ, Monk BJ, Berek JS, Souhami L, Grigsby P, Gordon W, Jr., Alberts DS: Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol, 18: 1606-1613, 2000. (Pubitemid 30220538)
18. Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, Clarke-Pearson DL, Insalaco S: Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med, 340: 1144-1153, 1999. (Pubitemid 29177873)
19. Whitney CW, Sause W, Bundy BN, Malfetano JH, Hannigan EV, Fowler WC, Jr., Clarke-Pearson DL, Liao SY: Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol, 17: 1339-1348, 1999. (Pubitemid 29220838)
20. Wang CJ, Lai CH, Huang HJ, Hong JH, Chou HH, Huang KG, Lin JD: Recurrent cervical carcinoma after primary radical surgery. Am J Obstet Gynecol, 181: 518-524, 1999. (Pubitemid 29453506)
21. Stehman FB, Bundy BN, DiSaia PJ, Keys HM, Larson JE, FowlerWC: Carcinoma of the cervix treated with radiation therapy. I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer, 67: 2776-2785, 1991.
22. Zaino RJ, Ward S, Delgado G, Bundy B, Gore H, Fetter G, Ganjei P, Frauenhoffer E: Histopathologic predictors of the behavior of surgically treated stage IB squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study. Cancer, 69: 1750-1758, 1992.
23. Jain P, Hunter RD, Livsey JE, Coyle C, Swindell R, Davidson SE: Salvaging locoregional recurrence with radiotherapy after surgery in early cervical cancer. Clin Oncol (R Coll Radiol), 19: 763-768, 2007. (Pubitemid 350011932)
24. Larson DM, Copeland LJ, Stringer CA, Gershenson DM, Malone JM Jr, Edwards CL: Recurrent cervical carcinoma after radical hysterectomy. Gynecol Oncol, 30: 381-387, 1988.
25. Webb MJ, Symmonds RE: Site of recurrence of cervical cancer after radical hysterectomy. Am J Obstet Gynecol, 138: 813-817, 1980.
26. Cerrotta A, Gardan G, Cavina R, Raspagliesi F, Stefanon B, Garassino I, Musumeci R, Tana S, De Palo G: Concurrent radiotherapy and weekly paclitaxel for locally advanced or recurrent squamous cell carcinoma of the uterine cervix. A pilot study with intensification of dose. Eur J Gynaecol Oncol, 23: 115-119, 2002. (Pubitemid 34297111)
27. Maneo A, Landoni F, Cormio G, Colombo A, Placa F, Pellegrino A, Mangioni C: Concurrent carboplatin/5-fluorouracil and radiotherapy for recurrent cervical carcinoma. Ann Oncol, 10: 803-807, 1999. (Pubitemid 29367997)
28. Miglietta L, Franzone P, Centurioni MG, Boni L, Tacchini L, Cosso M, Boccardo F, Ferrarini M, Bruzzone M: A phase II trial with cisplatin-paclitaxel cytotoxic treatment and con-current external and endocavitary radiation therapy in locally advanced or recurrent cervical cancer. Oncology, 70: 19-24, 2006.
29. Smaniotto D, D'Agostino G, Luzi S, Valentini V, Macchia G, Mantini G, Margariti PA, Ferrandina G, Scambia G: Concurrent 5-fluorouracil, mitomycin C and radiation with or without brachytherapy in recurrent cervical cancer: a scoring system to predict clinical response and outcome. Tumori, 91: 295-301, 2005. (Pubitemid 41433118)
30. Thomas GM, Dembo AJ, Myhr T, Black B, Pringle JF, Rawlings G: Long-term results of concurrent radiation and chemotherapy for carcinoma of the cervix recurrent after surgery. Int J Gynecol Cancer, 3: 193-198, 1993. (Pubitemid 23361855)
31. Windschall A, Ott OJ, Sauer R, Strnad V: Radiation therapy and simultaneous chemotherapy for recurrent cervical carcinoma. Strahlenther Onkol, 181: 545-550, 2005.
32. Mohiuddin M, Marks G, Marks J: Long-term results of reirradiation for patients with recurrent rectal carcinoma. Cancer, 95: 1144-1150, 2002.
33. Dogan N, King S, Emami B, Mohideen N, Mirkovic N, Leybovich LB, Sethi A: Assessment of different IMRT boost delivery methods on target coverage and normal-tissue sparing. Int J Radiat Oncol Biol Phys, 57: 1480-1491, 2003. (Pubitemid 37443991)
34. D'Souza WD, Ahamad AA, Iyer RB, Salehpour MR, Jhingran A, Eifel PJ: Feasibility of dose escalation using intensity- modulated radiotherapy in posthysterectomy cervical carcinoma. Int J Radiat Oncol Biol Phys, 61: 1062-1070, 2005. (Pubitemid 40340900)
35. Guerrero M, Li XA, Ma L, Linder J, Deyoung C, Erickson B: Simultaneous integrated intensity-modulated radiotherapy boost for locally advanced gynecological cancer: radiobiological and dosimetric considerations. Int J Radiat Oncol Biol Phys, 62: 933-939, 2005. (Pubitemid 40779789)
36. Kim YS, Shin SS, Nam JH, Kim YT, Kim YM, Kim JH, Choi EK: Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer. Gynecol Oncol, 108: 195-200, 2008.
37. Lee MY, Wu HG, Kim K, Ha SW, Kim JS, Kim IA, Lee HP: Concurrent radiotherapy with paclitaxel/carboplatin chemotherapy as a definite treatment for squamous cell carcinoma of the uterine cervix. Gynecol Oncol, 104: 95-99, 2007. (Pubitemid 46054128)